综述:肠易激综合征的自然史、排便习惯稳定性及与其他胃肠疾病的重叠
肠易激综合征(IBS)症状随时间波动,社区发病率约67/1000人年,患病率因症状波动及缓解与新发数量相近而保持稳定。人群研究中症状缓解比例为17%至55%,亚型间存在大量转换,IBS-M最不稳定。IBS症状与胃食管反流病等其他胃肠综合征重叠显著,识别重叠对正确诊断和避免过度检查有临床意义,自然史知识应纳入治疗决策。
要点
- IBS社区发病率约67/1000人年,患病率因症状波动而保持稳定。
- 人群研究中IBS症状缓解比例为17%至55%,亚型间转换常见,IBS-M最不稳定。
- IBS症状与胃食管反流病等胃肠综合征重叠显著,识别重叠有助于正确诊断并避免过度检查。
核心结论
- IBS症状随时间波动,亚型间转换常见,IBS-M最不稳定;IBS与其他胃肠疾病重叠显著,自然史知识应纳入治疗决策。
研究设计与样本
- 综述,检索范围未在原文中报告。
主要发现
- 社区IBS发病率约67/1000人年。
- 人群研究中IBS症状缓解比例为17%至55%。
- 临床试验队列中仅四分之一患者在整个研究期间保持基线分类,三分之二患者在IBS-C与IBS-M间转换,超过半数在IBS-D与IBS-M间转换。
- 最不稳定的亚型为IBS-M。
- 关于IBS排便习惯改变的驱动因素数据非常有限,肠道免疫活动波动的新兴证据可能解释症状随时间的变化。
临床怎么用
- 应识别IBS症状与胃食管反流病等其他胃肠综合征的显著重叠,以确保IBS的正确临床诊断并避免过度检查。
- 治疗决策时应考虑IBS的自然史、亚组稳定性及与其他胃肠疾病的重叠。
局限性
- 关于IBS排便习惯改变的驱动因素数据非常有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Symptoms of irritable bowel syndrome (IBS) characteristically fluctuate over time. We aimed to review the natural history of IBS and IBS subgroups including bowel habit disturbances, and the overlap of IBS with other gastrointestinal disorders. The community incidence of IBS is approximately 67 per 1000 person years. The prevalence of IBS is stable over time because symptoms fluctuate and there is a portion who experience resolution of their GI symptoms similar in number to those developing new-onset IBS. The proportion who report resolution of symptoms varies amongst population-based studies from 17% to 55%. There is evidence of substantial movement between subtypes of IBS. For example in a clinical trial cohort, only one in four patients retained their baseline classification throughout the study periods, two in three moved between IBS-C (constipation) and IBS-M (mixed), while over half switched between IBS-D (diarrhoea) and IBS-M. The least stable group was IBS-M. There are very limited data on drivers of bowel habit change in IBS. There are emerging evidence fluctuations in intestinal immune activity might account for symptom variability over time. It is of clinical importance to recognise the substantial overlap of IBS symptoms with other gastrointestinal syndromes including gastro-oesophageal reflux disease. This is important to ensure the correct clinical diagnosis of IBS is made and patients are not over investigated. Knowledge of the natural history, stability of subgroups and overlap of IBS with other gastrointestinal conditions should be considered in therapeutic decision making.
引用
- Yadav YS, Eslick GD, Talley NJ, et al. Review article: irritable bowel syndrome: natural history, bowel habit stability and overlap with other gastrointestinal disorders. Aliment Pharmacol Ther. 2021. PMID: 34927758. doi:10.1111/apt.16624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。